Aveeno Baby Shampoo Hypoallergenic Lawsuit (2026)
False Advertising · Lawsuit Filed

Aveeno Baby Shampoo Class Action Lawsuit — Suit Says "Hypoallergenic" Wash Contains Known Allergens

Published July 1, 2026

A newly filed class action says Kenvue's Aveeno Baby Daily Moisture Wash & Shampoo isn't truly "hypoallergenic" — independent testing allegedly found two known fragrance allergens hidden in the product's "fragrance" ingredient.

Aveeno Baby Daily Moisture Wash & Shampoo hypoallergenic class action lawsuit against Kenvue Brands
Allegations Only · No Settlement Yet

This article describes a class action complaint. The statements below are unproven allegations. Kenvue Brands, LLC has not been found liable, there is no certified class, and nothing to claim at this time. This page is informational and is not legal advice.

What Is This Lawsuit About?

A proposed class action filed May 7, 2026 in the U.S. District Court for the Northern District of California alleges that Kenvue Brands, LLC falsely markets its Aveeno Baby Daily Moisture Wash & Shampoo as "hypoallergenic" when, according to the complaint, the product contains known fragrance allergens.

The case is captioned Amado v. Kenvue Brands, LLC, No. 3:26-cv-04204-LJC. It is brought on behalf of a proposed California class and a proposed nationwide class of consumers who bought the shampoo. The complaint asserts claims for breach of express warranty, three separate theories under California's Unfair Competition Law, violations of the False Advertising Law and the Consumers Legal Remedies Act, and unjust enrichment.

At this stage these are only allegations. Kenvue has not responded to the merits, no class has been certified, and no court has ruled on whether the "hypoallergenic" claim is misleading.

Status Complaint Filed — Early Stage
Filed May 7, 2026 N.D. Cal. · Case No. 3:26-cv-04204-LJC
Product Aveeno Baby Daily Moisture Wash & Shampoo Sold by Kenvue Brands, LLC
Can I Claim? No — nothing to claim yet No settlement, no claim form. Watch this page for updates.

The Core Allegation: "Hypoallergenic" vs. d-Limonene and Linalool

The complaint's central theory mirrors a growing wave of "hypoallergenic" labeling suits against personal-care brands. The named plaintiff says she commissioned independent analytical testing of the shampoo in April 2026, after purchasing it online through Amazon. The testing reportedly used headspace gas chromatography coupled with mass spectrometry (GC/MS), a laboratory method used to identify fragrance constituents. According to the complaint, that testing detected d-Limonene and Linalool — two fragrance ingredients the lawsuit describes as being among 26 fragrance allergens the FDA has acknowledged, citing European Commission research, as among those that most commonly cause allergic reactions from cosmetic products.

The complaint alleges that neither allergen is listed by name on the label — both are said to be hidden components of the product's generic "fragrance" ingredient, discoverable only through laboratory testing. The plaintiff argues that intentionally including two recognized fragrance allergens directly contradicts a voluntary "hypoallergenic" claim, rendering it, in her words, false and misleading.

The suit frames "hypoallergenic" as communicating to a reasonable consumer that a product is formulated to reduce the likelihood of allergic reactions — including, at a minimum, by avoiding the intentional inclusion of known contact allergens. The complaint notes that the Food, Drug and Cosmetic Act does not define "hypoallergenic," but that the FDA has acknowledged manufacturers use the term to suggest a product is less likely to cause allergic reactions than competing products.

What the Plaintiff Says She Experienced

The complaint is brought by named plaintiff Tara Amado, a California resident who says she bought the shampoo at a Target store in San Bruno, California in March 2026. She says she read and relied on the "hypoallergenic" representation, understood it to mean the product was formulated to reduce allergic reactions and did not include recognized fragrance allergens, and would not have bought the product — or would have bought it on different terms — had she known what the testing allegedly showed.

The economic-injury theory here is a price-premium theory, not a personal-injury theory. The plaintiff does not claim the shampoo physically injured her. Instead, she alleges she overpaid because the "hypoallergenic" label commanded a premium and she did not receive the product she believed she was buying.

Who Could Be Covered If a Class Is Certified?

The complaint proposes two classes: a California class of all persons in California who purchased the shampoo in California during the applicable class period, and a nationwide class of all persons who purchased it in the United States during the applicable class period.

The complaint states the class period runs back as far as the statutes of limitation allow for each claim — three years for the CLRA and unjust-enrichment claims, four years for the UCL, False Advertising Law, and breach-of-warranty claims. No class has been certified, so these definitions could narrow, expand, or change as the case proceeds. The complaint estimates the proposed classes include tens of thousands of purchasers.

What the Lawsuit Is Asking For

The complaint seeks class certification, restitution or disgorgement of profits, compensatory and punitive damages and statutory penalties where available, an injunction barring the allegedly deceptive labeling and requiring corrective advertising, declaratory relief, attorneys' fees and costs, and a jury trial. The amount in controversy is alleged to exceed $5 million, the threshold for federal jurisdiction under the Class Action Fairness Act. The complaint also states that a Consumers Legal Remedies Act demand letter was served on Kenvue along with the complaint, and that the plaintiff may amend the complaint to seek additional CLRA damages if Kenvue does not properly address that demand within 30 days.

Is There a Settlement or a Claim Form?

No. This is a newly filed complaint in its early stage. There is no settlement, no settlement website, no settlement fund, and no claim form. No money is available, and there is nothing to sign up for right now.

If the case eventually settles or the plaintiff prevails, a court-approved notice and claims process would be established at that point, and eligible buyers would be told who is included and how to file. Be cautious of any site claiming you can "file an Aveeno baby shampoo claim" today — no legitimate claims process exists yet.

Is This Related to OCA's Earlier Aveeno Sunscreen Settlement?

No. OpenClassActions.com previously covered a separate, now-closed Aveeno and Neutrogena sunscreen settlement that resolved allegations that certain sunscreen products may have contained carcinogens; that case paid eligible households up to $21.16 in vouchers and closed in 2022. This lawsuit is unrelated — it targets a different product (Aveeno Baby Daily Moisture Wash & Shampoo), a different legal theory ("hypoallergenic" labeling), and a different defendant name (Kenvue Brands, LLC, the entity that now holds the Aveeno and Neutrogena brands after they were spun off from Johnson & Johnson's former Consumer Healthcare division in 2023). The only connection between the two cases is that both involve Kenvue-owned personal-care brands.

What Happens Next?

Kenvue will likely respond to the complaint, often with a motion to dismiss testing the legal theory — for example, whether a reasonable consumer would read "hypoallergenic" to promise the absence of every recognized fragrance allergen, and whether the plaintiff's testing supports her claims. If the case survives, the parties would move into discovery and a fight over class certification. Any of those stages can take many months to years. This page will be updated as the docket develops.

This is not the first "hypoallergenic" fragrance-allergen suit of its kind — see our coverage of the similar Dove Sensitive Hypoallergenic Body Wash lawsuit, which alleges d-Limonene in a Unilever product under a nearly identical legal theory.

Complaint PDF

Download the Full Class Action Complaint (PDF)

Frequently Asked Questions

Is this a settlement? Can I file a claim?

No. This is a newly filed lawsuit, not a settlement. There is no settlement fund, no claim form, and no money available at this time. If the case later settles or the plaintiff wins, a claims process would be announced through the court.

What product does the Aveeno lawsuit target?

The complaint targets Aveeno Baby Daily Moisture Wash & Shampoo, sold by Kenvue Brands, LLC. The suit focuses on the "hypoallergenic" claim on the product's packaging.

What does the lawsuit allege?

The complaint alleges that independent gas chromatography/mass spectrometry testing detected d-Limonene and Linalool, two of 26 fragrance allergens recognized by the FDA, in the product. The plaintiff argues that including known fragrance allergens makes the "hypoallergenic" label false and misleading. The allegations are unproven.

Who could be covered by the proposed class?

The complaint proposes a California class of people who bought the product in California and a nationwide class of people who bought it in the United States during the applicable class period. No class has been certified, so the definition could change.

Is this the same as OpenClassActions.com's earlier Aveeno sunscreen settlement?

No. This lawsuit is a separate, unrelated case about Aveeno Baby Daily Moisture Wash & Shampoo and "hypoallergenic" labeling. OpenClassActions.com previously covered a different, now-closed settlement over Neutrogena and Aveeno sunscreen products that allegedly may have contained carcinogens. Both brands are owned by Kenvue, the former Johnson & Johnson consumer health division, but the products, allegations, and legal claims are unrelated.



Sources

• Class action complaint, Amado v. Kenvue Brands, LLC, No. 3:26-cv-04204-LJC (N.D. Cal. filed May 7, 2026) — Complaint PDF
• U.S. Food & Drug Administration, Hypoallergenic Cosmetics
• U.S. Food & Drug Administration, Allergens in Cosmetics
• Alinaghi, F., et al., Prevalence of Contact Allergy in the General Population: A Systematic Review and Meta-Analysis, Contact Dermatitis (2018)

About This Lawsuit

This is an active, early-stage class action lawsuit. There is no settlement, no claim form, and no money available at this time. If the case results in a settlement or verdict, eligible consumers will be notified through the court system. OpenClassActions.com will update this page as the case progresses. OpenClassActions.com is a consumer advocacy and class action news site, and is not a class action administrator or a law firm.
For more class actions keep scrolling below.
Status Complaint Filed — Early Stage (No Settlement)
Case Title Amado v. Kenvue Brands, LLC
Case Number 3:26-cv-04204-LJC
Court U.S. District Court, Northern District of California
Date Filed May 7, 2026
Defendant Kenvue Brands, LLC
Product Aveeno Baby Daily Moisture Wash & Shampoo
Proposed Class California and nationwide buyers of the product during the applicable class period
Claims Breach of express warranty; UCL (unfair, fraudulent & unlawful); False Advertising Law; CLRA; unjust enrichment
Damages Sought Restitution/disgorgement, damages, penalties, injunctive relief, fees; jury demanded

More on Hypoallergenic & Personal Care Labeling Cases